Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The colonic mucin barrier refers to a specialized two-layer mucus system in the colon, essential for protecting the epithelium from luminal microbes and toxins. It consists of an inner, dense, bacteria-impermeable layer and an outer, looser layer inhabited by commensal bacteria. Both are primarily organized by the gel-forming mucin MUC2, which forms a highly glycosylated polymer secreted by goblet cells. Deficiency or dysfunction in this barrier (e.g., due to loss of MUC2) leads to direct microbial-epithelial contact, chronic inflammation, and heightened cancer risk[1][2][3][4][5]. The colonic mucin barrier is not a single molecular entity but a complex, dynamic structure vital for intestinal homeostasis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Colonic mucin barrier.